Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · International Stock · Goldman Sachs

Goldman Sachs International Tax-Managed Equity Fund Class C (GCTMX)

Ticker GCTMX · Since 2008-01-31 · · Holdings as of Jun 30, 2026

Expense ratio
1.96%$196/yr per $10k
5-yr return
+10.1%annualized
1-yr return
+37.0%as of Dec 2025
Net assets
$957.9Mall share classes
Holdings
301

Bottom line

Is GCTMX a good fund? The bottom line

GCTMX is the Class C share class of Goldman Sachs International Tax-Managed Equity Fund, an actively managed international stock mutual fund from Goldman Sachs.

Annual fees run 1.96% — about $196 a year on every $10,000 invested, more expensive than 96% of international stock funds we track.

It returned +37.0% over one year, +10.1% a year over five years, +8.1% a year over ten (as of Dec 31, 2025, per its prospectus).

With $958 million in net assets and 301 holdings, its largest position is Asml Holding Nv (3.5%) and the top 10 make up 17% of the portfolio.

What stands out

  • 5-year return beat 82% of category peers
  • Broadly diversified (301 holdings)
  • No front-end sales load

What to watch

  • Expensive for its category (1.96%)
  • 12b-1 marketing fee of 0.75% a year
  • High turnover (175% a year) can mean more taxable distributions

Updated Nov 19, 2026

What GCTMX invests in

The Goldman Sachs International Tax-Managed Equity Fund (the Fund) seeks to provide long-term after-tax growth of capital through tax-sensitive participation in a broadly diversified portfolio of international equity securities.

The Fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) (Net Assets) in equity investments in non-U.S. issuers. The Fund seeks broad representation of large-cap and mid-cap issuers across major countries and sectors of the international economy, with some exposure to small-cap issuers. The Fund uses a variety of quantitative techniques, in combination with a qualitative overlay, when selecting investments that have the potential to maximize the Funds after-tax return and minimize capital gains and income distributions. These quantitative techniques, which are derived from fundamental research and based on certain investment themes, including, among others, Fundamental Mispricings, High Quality Business Models, Sentiment Analysis and Market Themes & Trends. Fundamental Mispricings seeks…

From the fund's prospectus (filed Apr 29, 2026).

GCTMX performance

Average annual total returns
1 yr5 yr10 yr
GCTMX+37.0%+10.1%+8.1%
International Stock median+25.5%+6.4%+7.6%

Source: Fund prospectus, as of Dec 31, 2025

Full GCTMX performance history →

What GCTMX costs

On a $10,000 investment, GCTMX's 1.96% expense ratio costs about $196 a year. The prospectus estimates $2,401 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.

See the full GCTMX fee table →

GCTMX top 10 holdings

#Holding% of fund
1Asml Holding Nv ASML3.51%
2Novartis Ag NOVN1.79%
3Astrazeneca Plc AZN1.72%
4Siemens Ag SIE1.70%
5Murata Manufacturing Company Ltd 69811.57%
6Compagnie Financiere Richemont Sa CFR1.46%
7Abb Ltd (ch) ABBN1.41%
8Nestle' Sa/ag NESN1.38%
9Renesas Electronics Corp 67231.27%
10Safran Sa SAF1.21%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 17% of the fund. See all top 25 holdings and asset mix →

Alternatives to GCTMX

More funds like GCTMX →

GCTMX FAQ

What is the expense ratio of GCTMX?
GCTMX's expense ratio is 1.96%, which works out to about $196 a year for every $10,000 invested. The prospectus estimates total costs of $2,401 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is GCTMX a good investment?
It depends on your goals, but the data points to: 5-year return beat 82% of category peers; broadly diversified (301 holdings); no front-end sales load; expensive for its category (1.96%); 12b-1 marketing fee of 0.75% a year; high turnover (175% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does GCTMX hold?
GCTMX's largest holdings are Asml Holding Nv (3.5%), Novartis Ag (1.8%), Astrazeneca Plc (1.7%), Siemens Ag (1.7%), Murata Manufacturing Company Ltd (1.6%). It holds 301 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is GCTMX's 5-year return?
GCTMX returned +10.1% a year over the five years ending Dec 31, 2025, and +8.1% a year over ten years. Past performance does not guarantee future results.
Does GCTMX have a sales load?
No. GCTMX has no front-end sales charge. It may charge a deferred sales charge of up to 1% if sold early.
Who manages GCTMX?
GCTMX is offered by Goldman Sachs through Goldman Sachs Trust.